Debate and Discussion

This year, we have prepared 2 topics for the AGM. As usual, there is one medical and one non-medical topic. You can download the background information pack below.

25 August 2017 

"The burden of Hepatitis C in Asia. What is MSF’s role?"

  • Prevalence and burden of Hepatitis C infection in Asia Pacific
  • Hepatitis C project in Cambodia
  • Advocacy for affordable DAAs
  • Role of DNDi

Speakers:
Po Lin, Chan (WHO)
Mickael Le-Paih (HoM, Cambodia, OCP)
Leena Menghaney (Regional Head South Asia, Access Campaign)
Jean-Michael Piedagnel (Director of DNDi, SEA)

 

On 26 August 2017

"Debate: Emerging technologies Space technology & its applications in humanitarian work: Is it time for MSF to utilize this innovative technology in our humanitarian work? The negative reputation associated with drones is too toxic for MSF?"

  • Database network, cloud service and AI.
  • Cargo drones in MSF and PNG TB case study
  • Missing Maps - Map swipe app & Sapling Nursey

Speakers: 
Natasha Reyes (ERSU Manager, MSF Hong Kong)
Oriol Lopez (R&D Specialist, Innovation Centre, MSF Japan)
Pete Masters (Medical Innovation Advisor, MSF UK)

 

 

Speakers Info:

Po Lin, Chan (WHO)
Dr Po-Lin Chan is the Medical Officer (Viral Hepatitis) at the WHO Western Pacific Regional Office. Polin served as the Senior Advisor for Hepatitis, HIV and STI at the World Health Organization China country office.  She is a medical doctor trained in obstetrics and gynaecology, tropical medicine as well as epidemiology. She has worked across a variety of health settings spanning Africa, South Asia and East Asia from delivering medical and surgical services to communities suffering from war, to advising government on public health initiatives. Po-lin supported the establishment, scale-up and decentralisation of the comprehensive HIV/STI prevention, treatment and care programme in India during her service as the Team Leader HIV/STI at WHO India. In China, she works on the interlinked strategies on HIV, STI, and Viral Hepatitis towards elimination as public health threats by 2030.

 

Mickael Le-Paih (HoM, OCP Cambodia)

  •       Work for Pharmaciens sans Frontieres between 1994-1998 (Bosnia, Mongolia, Haiti-Afghanistan)
  •       Joined MSF in 1999, (worked as finance at Paris HQ from 2002-2006), then head of mission from 2006 till 2012.
  • Context emergency and post emergency responses (DRC, Malawi, Sri Lanka), Implementation of HIV/TB decentralized care (Malawi-SouthAfrica/Lesotho)
  •       2012 > 2016 I was a regional technical assistant with ECHO (Islamabad and later based Cairo)
  •       From June 2013 and October 2016,  I had a second hat. I was elected board member of MSF-France asso
  •       Since November 2016, back to OPS ! hom in Cambodia Hep C project.

 

Jean-Michel Piedagnel
Jean-Michel Piedagnel joined Drugs for Neglected Diseases Initiative, DNDi, as Head of the South-East Asia office based in Kuala Lumpur, in April 2016.  Prior to this position, he was a consultant for the non-profit sector as well as a member of the MSF Hong Kong Board from 2010 and an elected member of the International Board of MSF from 2013 to 2016. Jean-Michel joined MSF in 1995 to run some relief operations in DRC Goma, Burundi, Nigeria, Kosovo, Lebanon, Sierra Leone, Angola and Pakistan.  After working in the headquarters in Paris, he moved to London as the Executive Director for seven years until 2008. He is also a former board member of MSF Germany. Jean-Michel graduated from École de Commerce (ESCE), an international business school in Paris.

 

Leena Menghaney

Leena Menghaney is the South-Asia Head for MSF’s Access Campaign. Area of work and expertise is Public Health, Innovation and Intellectual Property. A graduate from the Dept of International Relations & Economic Studies, Jadavpur University, Calcutta she also has a LL.B degree from the University of Delhi.

In the last decade generic production in India has emerged as crucial for the supply of quality affordable medicines to the developing world, especially for newer drugs such as antiretrovirals (ARVs) for the treatment of HIV. She worked extensively on the people’s campaign for the inclusion of public health safeguards in the Patent (Amendment) Bill 2005, as its provisions seriously affected the production of affordable generic drugs and its supply to the developing world.

She is working with government, civil society and other stakeholders to implement public health safeguards in the Indian patent law. Since March 2005, her work involves providing technical support for legal challenges filed by public interest groups and people living with HIV/AIDS against pending patent applications covering HIV and other essential drugs for neglected co-infections. She has also been involved in providing legal analysis on various free trade agreements and bilateral investment treaties being negotiated by India with many developed countries. When multinational pharmaceutical company Novartis tried to challenge the public health safeguards in India’s patent law in 2006, MSF joined public interest groups in successfully opposing the pharmaceutical company’s legal action in order to safeguard India’s position as the ‘pharmacy of the developing world’. She has been coordinating this work from India for MSF’s Access Campaign. More recently, as part of the MSF Access Campaign team she has worked on addressing patent and regulatory barriers in India to encourage supply of low cost Direct Acting Antivirals for MSF’s medical projects in high burden Hepatitis C settings.    

 

Oriol Lopez

Doctors Without Borders R&D Specialist. Oriol is a research and development specialist for Doctors Without Borders. He is currently based in Tokyo and in charge of implementing a drone network for transporting medical items. The organization's aim is to develop drones with a range of 80 km (about 50 miles) carrying 2.5 kg of cargo in regular operations. Oriol is an engineer by trade. He has completed technical and logistics work in more than 20 countries. Between missions, he honed his skills designing, programming and building robots and drones. He’s also worked designing 3D printed prosthetics, and implemented renewable energy and shelter solutions for displaced populations.

Looking for operational and affordable cargo UAV solutions, he designed and built an electric fixed wing optimized for cargo with more than 120km of range and it’s twin quad plane version based on the same airframe. Both designed operationally for cargo, they have been successfully tested in Peruvian Amazonas in collaborations with WeRobotics and the MoH, delivering medical materials and carrying samples in outreach locations.

By: Wai Wai Lui